IPCA LABORATORIES
Back to Income Statement
|
IPCA LABORATORIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹547 Cr | ₹471 Cr | ₹884 Cr | ₹1,140 Cr | ₹606 Cr |
What is the latest Consolidated Net Profit of IPCA LABORATORIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹547 Cr |
| Mar2024 | ₹471 Cr |
| Mar2023 | ₹884 Cr |
| Mar2022 | ₹1,140 Cr |
| Mar2021 | ₹606 Cr |
How is Consolidated Net Profit of IPCA LABORATORIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹547 Cr | 16.13 | |
| Mar2024 | ₹471 Cr | -46.69 | |
| Mar2023 | ₹884 Cr | -22.45 | |
| Mar2022 | ₹1,140 Cr | 88.02 | |
| Mar2021 | ₹606 Cr | - | |
Compare Consolidated Net Profit of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹35,204.7 Cr | -3.2% | -4.5% | -10% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,590.0 Cr | -2% | -6.1% | -6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,577.0 Cr | -0.8% | -0.8% | 8.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,301.0 Cr | 0% | 2.7% | 11% | Stock Analytics | |
| CIPLA | ₹120,471.0 Cr | -0.6% | -2.6% | 0.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,660.0 Cr | -1.3% | 0.6% | -6.4% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -3.2% |
-4.5% |
-10% |
| SENSEX | -1% |
-1.2% |
7.9% |
You may also like the below Video Courses